Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Patton

Showing results (221-230 of 226) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 226 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2021
Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830]K L Jhaveri, X V Wang, V Makker, et al.
Nature Communications|January 25, 2023
Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNAAnna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Nature Communications|December 3, 2022
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNAAnna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.
NPJ Precision Oncology|March 2, 2022
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trialA S Mansfield, Z Wei, R Mehra, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Pageof 23

Showing results (221-230 of 226) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2021
Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830]K L Jhaveri, X V Wang, V Makker, et al.
Nature Communications|January 25, 2023
Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNAAnna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Nature Communications|December 3, 2022
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNAAnna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.
NPJ Precision Oncology|March 2, 2022
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trialA S Mansfield, Z Wei, R Mehra, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Pageof 23